Onco Therapies Limited (OTL), the wholly-owned oncology subsidiary of Strides, has received the UK's approval for Oxaliplatin injections in strengths of 5 mg per 10 ml, 5 mg per 20 ml and 5 mg per 40 ml, Strides Arcolab said in a statement.
"The current approval is from UK and approval for the rest of the European countries is expected shortly," it added.
2109
4199
519
775
198
899
1987
2798
8774
17548
1799
3599
9450
18899
450
500
5519
11099
349
499
735
1499
1002
1699
1100
1499
2191
2356